Suanfarma

About Suanfarma

Suanfarma founded in 1993, is a B2B life science partner committed to health & innovation by developing, manufacturing, and distributing high quality ingredients for the pharmaceutical industry, with 12 global offices serving over 400 clients in more than 70 countries.

At Suanfarma we provide comprehensive CDMO services for fermentation and chemical synthesis projects, offering a one-stop-shop solution with a proven track record for successful development, scaling, manufacturing, and commercialization of both innovative and generic APIs.

Read more Show less
Certifications
  • FDA
    FDA
  • GMP
    GMP
  • ISO
    ISO
More certifications Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • ES
  • 2015
    On CPHI since
  • 3
    Certificates
  • 500 - 999
    Employees
Company types
CMO/CDMO
Distributor/Import Export
Manufacturer/Innovator
Primary activities
API Producer
Contract Manufacturer
View company profile
Contact info
Show contact info Hide contact info
Meet us at

CPHI North America 2024

Pennsylvania Convention Center, Philadelphia
07 May 2024 - 09 May 2024
View Exhibitor Profile

CPHI & PMEC China 2024

Shanghai New International Expo Center
19 - 21 June 2024
View Exhibitor Profile

CPHI Milan 2024

Fiera Milano, Italy
08 Oct 2024 - 10 Oct 2024
View Exhibitor Profile

Products from Suanfarma (5)

Suanfarma Resources (1)

  • SUANFARMA - CORPORATE VIDEO

    Video SUANFARMA - CORPORATE VIDEO

    SUANFARMA was born in Spain in 1993 and is specialized in the development, production and commercialization of ingredients for the pharmaceutical, veterinary, and nutritional sectors. 

    During the last 5 years the company has achieved the highest growth in its history and has acquired 5 new companies in Spain, Portugal, Colombia and Italy, increasing significantly its industrial and development capacity. SUANFARMA Group is represented by over 650 people, with presence in over 70 countries.

    At SUANFARMA, we are committed to health and innovation. We develop new technologies and processes to offer innovative products, following the trends of the world of health and the needs of our customers. We cover both “super sales” molecules and niche molecules or specialized therapies, controlling the production process from the intermediate to the final product.
    2023-05-29